KCTD19 antibody
Principal name
KCTD19 antibody
Alternative names for KCTD19 antibody
BTB/POZ domain-containing protein KCTD19
Ncbi ID
XP_085367, ADR83413.1, NP_001094385.1, NP_808459.1, BC092530, NM_177791, NM_001100915
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB)
Background of KCTD19 antibody
- Kit Component:
- - KN308712G1, Kctd19 gRNA vector 1 in pCas-Guide vector
- KN308712G2, Kctd19 gRNA vector 2 in pCas-Guide vector
- KN308712D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Human Muscle; WB Suggested Anti-KCTD19 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:12500. Positive Control: Human Muscle; KCTD19 antibody - N-terminal region (ARP36784_P050) in Human Muscle cells using Western Blot
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR211212L2V | Lenti ORF particles, Kctd19 (GFP-tagged) - Mouse potassium channel tetramerisation domain containing 19 (cDNA clone MGC:107186 IMAGE:6744085), 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€1,470.00
|
|
| OriGene Technologies, Inc. | ||
| MR219964L2V | Lenti ORF particles, Kctd19 (GFP-tagged) - Mouse potassium channel tetramerisation domain containing 19 (Kctd19), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,810.00
|
|
| OriGene Technologies, Inc. | ||
| MR211212L1V | Lenti ORF particles, Kctd19 (Myc-DDK-tagged) - Mouse potassium channel tetramerisation domain containing 19 (cDNA clone MGC:107186 IMAGE:6744085), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,330.00
|
|
| OriGene Technologies, Inc. | ||
| MR219964L1V | Lenti ORF particles, Kctd19 (Myc-DDK-tagged) - Mouse potassium channel tetramerisation domain containing 19 (Kctd19), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,630.00
|
|
| OriGene Technologies, Inc. | ||
